127 related articles for article (PubMed ID: 2367445)
1. [Significance of the acetylator phenotype and initial oral/intravenous rifampicin administration in the treatment of tuberculosis].
Loos U; Musch E; Schwabe HK
Pneumologie; 1990 Feb; 44 Suppl 1():488-9. PubMed ID: 2367445
[TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability of rifampicin, isoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol.
Schall R; Müller FO; Duursema L; Groenewoud G; Hundt HK; Middle MV; Mogilnicka EM; Swart KJ
Arzneimittelforschung; 1995 Nov; 45(11):1236-9. PubMed ID: 8929247
[TBL] [Abstract][Full Text] [Related]
3. [Tisamide in the complex treatment of tuberculosis].
Onishchenko VV; Sokolova GB; Koriakin VA; Shapatava MN; Iurchenko LN
Probl Tuberk; 1990; (7):43-5. PubMed ID: 2235951
[TBL] [Abstract][Full Text] [Related]
4. [Intravenous rifampicin therapy in open tuberculosis].
Loos U; Musch E; Mackes KG; Reetz KP; Gläser R; Schwabe HK; Hengstmann J; Eichelbaum M
Med Welt; 1983 Jun; 34(24):701-3. PubMed ID: 6888237
[No Abstract] [Full Text] [Related]
5. Simplified short-course treatment of pulmonary tuberculosis: experience with a regimen of ethambutol, rifampicin and isoniazid for 2 months followed by isoniazid or rifampicin for 4 months.
Gonzalez Montaner LJ; Leston JM; Cetrangolo A; Szemzo J; Calvete C; Dambrosi A; Mosca C
Bull Int Union Tuberc; 1976; 51(1):87-9. PubMed ID: 1030316
[No Abstract] [Full Text] [Related]
6. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-pharmacological approach to rifampicin and isoniazid dosage].
Karkishchenko NN; Khoron'ko VV; Vorob'ev VS; Anisimova NB; Chubarian VT
Probl Tuberk; 1987; (9):31-4. PubMed ID: 3422964
[No Abstract] [Full Text] [Related]
8. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
Dubra F
Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
[No Abstract] [Full Text] [Related]
9. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
[TBL] [Abstract][Full Text] [Related]
10. [Long term results of short course chemotherapy in pulmonary tuberculosis--(1st study):twelve- and eighteen-month chemotherapy with rifampicin-isoniazid and ethambutol].
Baba H; Schinkai A; Izuchi R; Azuma Y
Kekkaku; 1986 Jul; 61(7):371-7. PubMed ID: 3761792
[No Abstract] [Full Text] [Related]
11. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
12. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
Oka S; Sasaki M; Kobayashi T; Matsuda T
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
[No Abstract] [Full Text] [Related]
13. [Simultaneous study of the induction effect of rifampicin and the phenotype for acetylation of isoniazid in 21 patients with tuberculosis undergoing a combination treatment].
Chailleux E; Ordronneau J; Le Normand Y; Kergueris MF; Larousse C
Rev Fr Mal Respir; 1980; 8(3):219-24. PubMed ID: 7187065
[TBL] [Abstract][Full Text] [Related]
14. Single dose kinetics of rifampicin and isoniazid in well-nourished and malnourished patients of tuberculosis.
Garg SK; Dhand R; Malik SK; Kalra S; Gupta PH; Jha VK; Shukla VK; Lal R
Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):417-20. PubMed ID: 3220617
[TBL] [Abstract][Full Text] [Related]
15. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
16. Rifampicin serum levels in childhood tuberculosis.
Thee S; Detjen A; Wahn U; Magdorf K
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1106-11. PubMed ID: 19723399
[TBL] [Abstract][Full Text] [Related]
17. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
Ubaĭdullaev AM; Belotserkovets VG
Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetic aspects of tuberculosis therapy with a fixed combination of rifampicin, isoniazide and pyrazinamide].
Schaberg T; Lode H
Z Gesamte Inn Med; 1991 Jun; 46(8):276-9. PubMed ID: 1897286
[TBL] [Abstract][Full Text] [Related]
19. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)].
Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627
[No Abstract] [Full Text] [Related]
20. Serum concentrations of antimycobacterial drugs in patients with pulmonary tuberculosis in Botswana.
Tappero JW; Bradford WZ; Agerton TB; Hopewell P; Reingold AL; Lockman S; Oyewo A; Talbot EA; Kenyon TA; Moeti TL; Moffat HJ; Peloquin CA
Clin Infect Dis; 2005 Aug; 41(4):461-9. PubMed ID: 16028152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
